SKN | Morgan Stanley Reaffirms Its TJX Buy Call as the Retailer’s Stock Slides

Key Takeaways:

• Morgan Stanley has reiterated its Overweight rating on TJX Companies and maintained a $178 price target despite the stock’s sharp recent decline.
• The bank views TJX as a “consumer compounder” capable of producing durable earnings growth across economic cycles.
• Morgan Stanley identifies operational issues at TJX’s Marmaxx division as largely fixable execution problems rather than evidence of a deteriorating business model.
• The bank’s thesis depends on TJX restoring sales momentum while preserving the earnings characteristics that have supported its long-term franchise.

Morgan Stanley is standing behind its positive view of TJX Companies after a significant decline in the retailer’s shares. Analyst Alex Straton reiterated an Overweight rating and a $178 price target, signaling that the bank views the recent weakness as an execution setback rather than a fundamental break in TJX’s long-term earnings model.

Morgan Stanley Sees TJX’s Core Franchise as Intact

The bank’s thesis centers on TJX as a “consumer compounder”—a business capable of steadily expanding earnings through different economic conditions. That distinction is important to Morgan Stanley because the recent share-price pressure has been accompanied by weaker performance at Marmaxx, TJX’s largest division.

As of September 3, the stock had fallen approximately 16% over the previous month, creating a considerably more demanding market backdrop for the retailer. Morgan Stanley nevertheless maintained its $178 target, implying substantial upside from the roughly $131 level at which the shares were trading in early September.

The Bank Identifies Execution Rather Than Structural Damage

Morgan Stanley’s analysis focuses particularly on Marmaxx, which combines TJ Maxx, Marshalls and Sierra. Comparable sales increased only 1% in the second quarter, materially below the growth recorded across several other TJX divisions.

Rather than interpreting that slowdown as evidence that the broader TJX model is failing, Morgan Stanley points to operational shortcomings that management can address. Inventory was reportedly not reaching sales floors efficiently, while merchandise decisions around everyday apparel and back-to-school products weakened the division’s execution.

The bank also highlighted concerns surrounding beauty merchandise and whether TJX’s pricing advantage remains as pronounced when competing retailers become more aggressive with promotions. These issues matter because TJX’s model depends heavily on customer perception of value and the treasure-hunt shopping experience.

TJX’s Response Becomes Central to Morgan Stanley’s Thesis

The significance of Morgan Stanley’s continued Overweight rating is therefore tied to management’s ability to correct these issues. TJX Chief Executive Ernie Herrman described the Marmaxx shortfall as self-inflicted and within the company’s control, reinforcing the argument that the weakness may be operational rather than structural.

For Morgan Stanley, this creates a relatively straightforward test: if TJX can improve inventory execution, merchandise selection and store productivity, the company can potentially restore sales momentum without fundamentally changing its business model.

The $178 Target Requires Execution to Follow the Conviction

Morgan Stanley’s decision to maintain its target despite the selloff shows that the bank is placing greater weight on TJX’s long-term earnings compounding potential than on the latest weakness in Marmaxx. But that conviction also raises the importance of execution.

For sophisticated investors, the key issue is not simply the distance between the current share price and Morgan Stanley’s target. It is whether TJX can demonstrate that operational fixes translate into stronger comparable sales, resilient margins and sustained earnings growth. The next phase of the thesis rests with management’s ability to prove that the recent setback is temporary.

For a confidential discussion regarding your global equity exposure and cross-border wealth strategy, contact our senior advisory team.